Sou Hu Cai Jing·2025-07-31 10:21Group 1: Market Performance - Major indices declined on July 31, with the Shanghai Composite Index down 1.18%, Shenzhen Component down 1.73%, ChiNext down 1.66%, and the STAR Market down 1.01%. Over 1,000 stocks rose in the two markets, with a total trading volume of approximately 1.94 trillion yuan [2] - The AI sector showed strong performance, with stocks like Kexin New Energy (300731.SZ) rising 12.82%, and Industrial Fulian (601138.SH) and Youke De (688158.SH) both increasing over 6% [2] Group 2: AI Industry Growth - According to CCID Consulting, China's AI industry is expected to experience explosive growth this year, leading the global market. The industry is projected to grow from 398.5 billion yuan in 2025 to 1,729.5 billion yuan by 2035 [2] Group 3: Assisted Reproductive Technology Stocks - Stocks related to assisted reproduction surged, with Anke Bio (300009.SZ) and Gongtong Pharmaceutical (300966.SZ) both rising 20%, and Guangshengtang (300436.SZ) increasing over 18% [3] - The Ministry of Finance announced a budget of 90 billion yuan for a new "child-rearing subsidy fund" as part of a broader initiative to support fertility policies [3] Group 4: Innovative Pharmaceuticals - Innovative drug stocks also performed well, with Zhendong Pharmaceutical (300158.SZ) rising over 16% and Shutaishen (300204.SZ) increasing over 10% [3] - According to Industrial Securities, China's innovative drug industry is transitioning to a leading position, with significant opportunities expected in 2025 as many products are projected to exceed 3 to 5 billion USD in peak sales [3] Group 5: Declining Sectors - The anti-involution sector saw significant declines, with steel, coal, and photovoltaic sectors being heavily impacted. Stocks like Baogang Co. (600010.SH) and Anyang Steel (600569.SH) fell over 7% [4] - Other sectors such as real estate, securities, liquor, film, and precious metals also showed weakness, with stocks like Happiness Blue Ocean (300528.SZ) dropping over 8% [4]